Results 21 to 30 of about 1,460,646 (299)

Lobar lung transplantation-Is it comparable with standard lung transplantation? [PDF]

Transplant International, 2014
Objective: Lobar lung transplantation (LLuTX) is a therapeutic option mainly for urgent small recipients. Only series with limited numbers have been reported. This approach is technically more demanding than standard LuTX or simple downsizing by wedge resections. In our center this approach was liberally[for full text, please go to the a.m. URL]
Alexis Slama, Bahil Ghanim, Thomas Klikovits, Axel Scheed, Mir A. Hoda, Konrad Hoetzenecker, Peter Jaksch, Jose Matilla, Sharokh Taghavi, Walter Klepetko, Clemens Aigner   +10 more
openaire   +3 more sources

Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures

Life, 2022
Background: Acute cellular rejection (ACR) is a complication after lung transplantation (LTx). The diagnosis of ACR is based on histologic findings using transbronchial forceps biopsy (FB). However, its diagnostic accuracy is limited because of the small
Carolin Steinack, Ariana Gaspert, Fiorenza Gautschi, René Hage, Bart Vrugt, Alex Soltermann, Macé Matthew Schuurmans, Daniel Franzen   +7 more
doaj   +1 more source

Postoperative surgical complications after lung transplantation

Revista Portuguesa de Pneumologia (English Edition), 2015
This is a review article on the main postoperative complications after lung transplantation: airways complications, vascular complications, pleural complications, surgical wound complications, and abdominal complications.Incidence data, severity, and ...
M. de la Torre, R. Fernández, E. Fieira, D. González, M. Delgado, L. Méndez, J.M. Borro   +6 more
doaj   +1 more source

Case Report: Esophagectomy and Azygos Continuation of the Inferior Vena Cava: A Lethal Combination

Frontiers in Cardiovascular Medicine, 2022
Azygos continuation of the inferior vena cava (IVC) is rare in the general population and even rarer among patients with esophageal carcinoma. In 90% of cases, this congenital IVC variant is isolated and does not affect the patient’s growth or ...
Yan Zhang, Zheng Ding, Teng Mu, Xue Pan, Guoqing Zhang, Xiangnan Li   +5 more
doaj   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba, Shweta Bansal, Tea Reljic, Allyne Montecillo‐Aguelo, Hamidah Alias, Farrah Amaranto, Maria Stella Aquino‐Calingasan, Bambang Ardianto, Eggi Arguni, Sally Blair, Thi Tam Dang, Maria Beatriz Gepte, Samanmalee Gunasekara, Andini Handayani, Miriam Kimpo, Catherine G. Lam, Nawachai Lertvivatpong, Sergio Licona, Ana Loseo, Ratha Mlis, Vivian Moreno Berrio, Nguyen Hoai Anh, Anna Lisa Ong‐Lim, Ha Thu Pham, Krishna Sagar Sharma, Bun Sereyleak, Sally Jane G. Velasco‐Aro, Su Yadana, Ambuj Kumar, Sheena Mukkada   +29 more
wiley   +1 more source

Use of Rifampicin as a Cytochrome Inducer in Acute Tacrolimus Poisoning

Open Respiratory Archives
Tacrolimus is an essential immunosuppressive drug in lung transplantation. It is metabolized by cytochrome P450, which can cause interactions with many drugs.
Juan Margallo Iribarnegaray, Rodrigo Alonso Moralejo, Carlos Andrés Quezada Loaiza, Lucía Ortega Ruiz, María Ruiz Rodriguez, Alicia De Pablo Gafas   +5 more
doaj   +1 more source

Characteristics, Survival, and Outcomes of Lung and Heart-Lung Transplantation for Pulmonary Sarcoidosis in a Multicenter European Study Characteristics, Survival, and Outcomes of Lung and Heart-Lung Transplantation for Pulmonary Sarcoidosis in a Multicenter European Study

, 2020
PURPOSE: In the context of sarcoidosis, lung transplantation is often performed in patients with irreversible advanced lung disease unresponsive to medical therapy.
Reynaud-Gaubert, M., Gottlieb, J., Tissot, A., Knoop, C., Pavec, J. L., Schultz, H., Blanchard, E., Godinas, L., Leborgne, A., Harari, S., Bunel, V., Magnusson, Jesper,, Mornex, J., Gazengel, P., Fadel, E., Picard, C., Savale, L., Valeyre, D., Hirschi, S.   +18 more
core   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Primary Erlotinib Resistance in a Patient with Non-Small Cell Lung Cancer Carrying Simultaneous Compound EGFR L718A, Q849H, and L858R Mutations

Biomolecular Concepts, 2021
Nowadays, mutations in the epidermal growth factor receptor (EGFR) kinase domain are studied in targeted therapy of non-small cell lung cancer (NSCLC) with EGFR tyrosine kinase inhibitors including gefitinib and erlotinib.
Mirtavoos-mahyari Hanifeh, Rismani Elham, Lotfabadi Alireza Sarkar, Dezfouli Azizollah Abbasi, Sheikhy Kambiz, Dezfuli Mojtaba Mokhber, Heshmatnia Jalal   +6 more
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source